New Study Examines Two Environmental Triggers in Type 1 Diabetes

Type 1 diabetes is an autoimmune disease where the body's immune system mistakenly attacks the insulin-producing beta cells in the pancreas. While genetics play a major role in determining who develops T1D, scientists know that environmental factors must also be involved—not everyone with T1D genes develops the disease.

Researchers have long suspected that infections or exposures to certain organisms might trigger or accelerate this autoimmune process. Two candidates have drawn particular attention: Mycobacterium avium subspecies paratuberculosis (MAP), a bacterium found in some food and water sources, and human endogenous retroviruses (HERVs), ancient viral sequences embedded in our DNA that can sometimes become active.

A research team in Tunisia designed a study to look for antibodies—immune proteins that target specific invaders—against MAP and HERV in the blood of children newly diagnosed with Type 1 diabetes. They tested 56 children with newly diagnosed T1D, their healthy siblings, and control groups.

The researchers used laboratory tests called ELISAs to measure antibodies against specific protein pieces from MAP and two families of HERV. They also looked for antibodies against human proteins that share structural similarities with these microbial proteins, a phenomenon called molecular mimicry. The theory is that the immune system might attack these human proteins by mistake after being triggered by the similar microbial versions.

The study found distinct antibody signatures in newly diagnosed T1D patients when compared to their healthy siblings and controls. Specifically, children with newly diagnosed T1D showed different patterns of antibodies against MAP epitopes (specific regions of MAP proteins) and against HERV envelope proteins.

These differences suggest that exposure or immune response to MAP and HERV may be associated with T1D development. However, the presence of antibodies alone does not prove these organisms directly cause T1D—only that they appear more frequently in children around the time of diagnosis.

This is the first study to examine MAP and HERV antibodies in Tunisian T1D patients, expanding our understanding of whether these environmental factors play a role across different populations. The findings align with earlier research from other populations suggesting these organisms may be linked to T1D development.

However, important questions remain unanswered. The study was conducted at a single point in time—after T1D diagnosis—so researchers cannot determine whether these antibodies actually triggered the disease or simply appeared as a result of it. Larger studies following people over time, before and after diagnosis, would be needed to establish a clearer cause-and-effect relationship.

Understanding environmental triggers may eventually help identify which children are at highest risk and whether preventing or treating certain infections could reduce T1D incidence. For now, this research contributes one more piece to the complex puzzle of Type 1 diabetes development.

Source: Cell biochemistry and biophysics. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.